Drug Trial Radar · NCT02614261
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
Last checked: Nov 20, 2026Latest source record: May 18, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,117
Actual
Start
Nov 30, 2015
Primary completion
Mar 16, 2017
Study completion Jul 14, 2021
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Nov 25, 2015
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main purpose of this study is to evaluate the efficacy of the study drug known as galcanezumab in participants with chronic migraine.
Conditions
- Chronic Migraine
Interventions
GalcanezumabDrug
Administered SC
PlaceboDrug
Administered SC
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall Mean Change From Baseline in the Number of Monthly Migraine Headache Days (MHD)Time frame: Baseline, Month 1 through Month 3
Locations
117 sites in 13 countries. Site status is shown where the registry gives one.
21st Century Neurology
Phoenix, Arizona
Arizona Research Center
Phoenix, Arizona
Pharmacology Research Institute, Encino
Encino, California
Fullerton Neurology and Headache Center
Fullerton, California
Pharmacology Research Institute, Los Alamitos
Los Alamitos, California
Pharmacology Research Institute, Newport Beach
Newport Beach, California
Desert Valley Research
Rancho Mirage, California
Anderson Clinical Research
Redlands, California
Artemis Institute for Clinical Research
San Diego, California
Medical Center for Clinical Research
San Diego, California
Optimus Medical Group
San Francisco, California
Colorado Neurological Institute
Englewood, Colorado
Advanced Neurosciences Research, LLC
Fort Collins, Colorado
Associated Neurologists of Southern Connecticut
Fairfield, Connecticut
Avail Clinical Research LLC
DeLand, Florida
Clinical Neuroscience Solutions Inc
Jacksonville, Florida
|Renstar Medical Research
Ocala, Florida
Psychiatric Inst of Florida-Clinical Neuroscience Solutions
Orlando, Florida
Compass Research
Oviedo, Florida
Premiere Research Institute at Palm Beach Neurology
West Palm Beach, Florida
Northwest Clinical Trials
Boise, Idaho
Christie Clinic, LLC
Champaign, Illinois
Robbins Headache Clinic
Riverwoods, Illinois
Midwest Institute for Clinical Research
Indianapolis, Indiana
Phoenix Medical Research, Inc
Prairie Village, Kansas
Heartland Research Associates
Wichita, Kansas
PharmaSite Research Inc
Baltimore, Maryland
Boston Clinical Trials Inc
Boston, Massachusetts
Michigan Head, Pain and Neurological Institute
Ann Arbor, Michigan
Clinical Research Institute
Minneapolis, Minnesota
Healthcare Research Network - Hazelwood
Hazelwood, Missouri
ClinVest
Springfield, Missouri
Albuquerque Clinical Trials
Albuquerque, New Mexico
Dent Neurological Institute
Amherst, New York
Island Neuro Associates,PC
Plainview, New York
Univ of Cincinnati College of Medicine
Cincinnati, Ohio
Healthcare Research Consultant
Tulsa, Oklahoma
Preferred Primary Care Physicians
Pleasant Hills, Pennsylvania
Abington Neurological Associates
Willow Grove, Pennsylvania
Clinical Trials of South Carolina
Charleston, South Carolina
Showing 40 of 117 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.